INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,998 | -18.6% | 2,100 | 0.0% | 0.00% | +100.0% |
| Q1 2024 | $57,771 | -41.9% | 2,100 | -46.0% | 0.00% | -66.7% |
| Q4 2023 | $99,364 | +3042.4% | 3,889 | +3789.0% | 0.00% | – |
| Q3 2023 | $3,162 | -22.5% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $4,078 | +9.4% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $3,727 | +124133.3% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -61.1% | 100 | -33.3% | 0.00% | – |
| Q4 2021 | $18,000 | -70.0% | 150 | -66.7% | 0.00% | -100.0% |
| Q3 2021 | $60,000 | +57.9% | 450 | +125.0% | 0.00% | +100.0% |
| Q2 2021 | $38,000 | +137.5% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |